Cargando…
Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis
Gemcitabine is the first-line chemotherapy drug for cholangiocarcinoma (CCA), but acquired resistance has been frequently observed in CCA patients. To search for potential long noncoding RNAs (lncRNAs) involved in gemcitabine resistance, two gemcitabine resistant CCA cell lines were established and...
Autores principales: | Lu, Min, Qin, Xinglei, Zhou, Yajun, Li, Gang, Liu, Zhaoyang, Geng, Xiwen, Yue, Haodi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803957/ https://www.ncbi.nlm.nih.gov/pubmed/33436545 http://dx.doi.org/10.1038/s41419-020-03346-4 |
Ejemplares similares
-
The Emerging Roles of LINC00665 in Human Cancers
por: Zhu, Jing, et al.
Publicado: (2022) -
LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics
por: Zhong, Chenming, et al.
Publicado: (2022) -
The Biological and Molecular Function of LINC00665 in Human Cancers
por: Zhang, Cheng, et al.
Publicado: (2022) -
A Concise Review on Dysregulation of LINC00665 in Cancers
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022) -
Long non-coding RNA LINC00665 gastric cancer tumorigenesis by regulation miR-149-3p/RNF2 axis
por: Qi, Hongyang, et al.
Publicado: (2019)